An infant develops petechiae within hours of birth and has a platelet count of 21,000/µL. The most likely diagnosis is:

An infant develops petechiae within hours of birth and has a platelet count of 21,000/µL. The most likely diagnosis is:

• A. Drug induced immune thrombocytopenia
• B. Thrombotic thrombocytopenic purpura
• C. Autoimmune neonatal thrombocytopenia
• D. Neonatal idiopathic thrombocytopenia

Answer: (D)

The key idea here is that severe, early-onset thrombocytopenia in a newborn with petechiae often points to an immune-mediated process occurring at birth. When no specific cause is identified—no maternal drug exposure, no clear alloimmune antibody problem, and no other syndromic clues—the diagnosis given to a newborn with persistent low platelets is neonatal idiopathic thrombocytopenia. It’s essentially a diagnosis of exclusion for the neonate who presents with marked thrombocytopenia at or soon after birth. In this scenario, the infant has a very low platelet count (21,000/µL) with petechiae appearing within hours of birth, which fits an immune-mediated mechanism that happens perinatally. If there were a known maternal autoimmune condition or a known drug exposure causing neonatal immune thrombocytopenia, that would push the diagnosis toward a condition tied to those specifics. If a distinct pathophysiology like thrombotic microangiopathy were suspected, or if there were signs of hemolysis and organ involvement typical of that disease, the scenario would point away from neonatal idiopathic thrombocytopenia. Likewise, autoimmune neonatal thrombocytopenia (due to maternal autoantibodies) would require evidence of maternal autoimmune disease or known antibody-mediated processes. So, without identifying a more specific cause, neonatal idiopathic thrombocytopenia best fits the presentation of abrupt, severe thrombocytopenia with petechiae at birth.

The key idea here is that severe, early-onset thrombocytopenia in a newborn with petechiae often points to an immune-mediated process occurring at birth. When no specific cause is identified—no maternal drug exposure, no clear alloimmune antibody problem, and no other syndromic clues—the diagnosis given to a newborn with persistent low platelets is neonatal idiopathic thrombocytopenia. It’s essentially a diagnosis of exclusion for the neonate who presents with marked thrombocytopenia at or soon after birth.

In this scenario, the infant has a very low platelet count (21,000/µL) with petechiae appearing within hours of birth, which fits an immune-mediated mechanism that happens perinatally. If there were a known maternal autoimmune condition or a known drug exposure causing neonatal immune thrombocytopenia, that would push the diagnosis toward a condition tied to those specifics. If a distinct pathophysiology like thrombotic microangiopathy were suspected, or if there were signs of hemolysis and organ involvement typical of that disease, the scenario would point away from neonatal idiopathic thrombocytopenia. Likewise, autoimmune neonatal thrombocytopenia (due to maternal autoantibodies) would require evidence of maternal autoimmune disease or known antibody-mediated processes.

So, without identifying a more specific cause, neonatal idiopathic thrombocytopenia best fits the presentation of abrupt, severe thrombocytopenia with petechiae at birth.